Voyageur Pharmaceuticals Ltd. News
-
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
March 13, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Corporation”), announces a…
-
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
March 4, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Corporation”) and Applied Pharmaceutical…
-
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement
March 1, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (“Voyageur” or the “Company”), a provider of innovative…
-
Voyageur Pharmaceuticals Ltd. Announces Private Placement
January 16, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (“Voyageur” or the “Company”), a provider of innovative…
-
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule
December 21, 2023 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative medical imaging…
-
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
December 21, 2023 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative…
-
Voyageur Pharmaceuticals Initiates International Expansion
December 14, 2023 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative medical imaging solutions,…
